SCHEMBL12415487

SCHEMBL12415487

C=CC1CC(C=C)C2C(=O)N(CCC)C(=O)C12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
RAB9A P51151 1/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP19A1 P11511 3/20 0.36
POLB P06746 1/20 0.35
PKM P14618 1/20 0.35
CTDSP1 Q9GZU7 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CNR2 P34972 3/20 0.34
CNR1 P21554 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
USP2 O75604 1/20 0.33
TSHR P16473 1/20 0.33
HTT P42858 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MAPT P10636 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12415484 0.90 SMN1; SMN2 (0.49) ALDH1A1SMN1; SMN2MEN1KMT2ARAB9A
SCHEMBL12415489 0.88 CNR2 (0.48) ALDH1A1SMN1; SMN2MEN1KMT2ARAB9A
SCHEMBL12415479 0.85 ALDH1A1 (0.36) ALDH1A1SMN1; SMN2MEN1KMT2ARAB9A
SCHEMBL18117671 0.82 ALDH1A1 (0.37) ALDH1A1MEN1KMT2ARAB9AKDM4E
SCHEMBL12415492 0.81 ALDH1A1 (0.34) ALDH1A1SMN1; SMN2MEN1KMT2ARAB9A
SCHEMBL18098028 0.81 ALDH1A1 (0.33) ALDH1A1HTT
SCHEMBL12415510 0.79 ALDH1A1 (0.34) ALDH1A1POLBPKMCTDSP1TDP1
SCHEMBL12415477 0.79 ALDH1A1 (0.32) ALDH1A1KMT2A
SCHEMBL18098039 0.78 USP2 (0.41) ALDH1A1MEN1KMT2ARAB9AKDM4E
SCHEMBL12415494 0.78 ALDH1A1 (0.36) ALDH1A1SMN1; SMN2MEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140080984-A1 HIGHLY ACTIVE METATHESIS CATALYSTS SELECTIVE FOR ROMP AND RCM REACTIONS ZANNA SCITECH CO., LTD. (CN) 2014-03-20 US disclosed
US-20110172381-A1 HIGHLY ACTIVE METATHESIS CATALYSTS SELECTIVE FOR ROMP AND RCM REACTIONS ZANNA SCITECH CO., LTD. (CN) 2011-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172381-A1 HIGHLY ACTIVE METATHESIS CATALYSTS SELECTIVE FOR ROMP AND RCM REACTIONS RCSD1, RRP12, TIAM1 ALDH1A1 3240/4885SMN1; SMN2 2598/4885MEN1 1844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.